These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 30524124

  • 1. Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13.
    Michael M, Turner N, Elenberg E, Shaffer LG, Teruya J, Arar M, Hui SK, Smith RJ, Moake J.
    Clin Kidney J; 2018 Dec; 11(6):791-796. PubMed ID: 30524124
    [Abstract] [Full Text] [Related]

  • 2. Atypical hemolytic uremic syndrome due to factor H autoantibody.
    Uslu-Gökceoğlu A, Doğan CS, Comak E, Koyun M, Akman S.
    Turk J Pediatr; 2013 Dec; 55(1):86-9. PubMed ID: 23692839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C.
    Blood; 2008 Feb 01; 111(3):1512-4. PubMed ID: 18006700
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
    Song D, Liu XR, Chen Z, Xiao HJ, Ding J, Sun SZ, Liu HY, Guo WY, Wang SX, Yu F, Zhao MH, Chinese Renal–TMA Network Institutes.
    Pediatr Nephrol; 2017 May 01; 32(5):811-822. PubMed ID: 28035470
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome.
    Trojnár E, Józsi M, Uray K, Csuka D, Szilágyi Á, Milosevic D, Stojanović VD, Spasojević B, Rusai K, Müller T, Arbeiter K, Kelen K, Szabó AJ, Reusz GS, Hyvärinen S, Jokiranta TS, Prohászka Z.
    Front Immunol; 2017 Apr 10; 8():302. PubMed ID: 28424685
    [Abstract] [Full Text] [Related]

  • 15. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG, Kirsztajn GM.
    J Bras Nefrol; 2010 Apr 10; 32(3):303-15. PubMed ID: 21103695
    [Abstract] [Full Text] [Related]

  • 16. Blockade of the Terminal Complement Cascade Using Ravulizumab in a Pediatric Patient With Anti-complement Factor H Autoantibody-Associated aHUS: A Case Report and Literature Review.
    Wu X, Szarzanowicz A, Garba A, Schaefer B, Waz WR.
    Cureus; 2021 Nov 10; 13(11):e19476. PubMed ID: 34912617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mycoplasma pneumoniae Infection Associated with Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome.
    Valoti E, Piras R, Mele C, Alberti M, Liguori L, Breno M, Bertulli C, Bresin E, Donadelli R.
    Nephron; 2022 Nov 10; 146(6):593-598. PubMed ID: 35405682
    [Abstract] [Full Text] [Related]

  • 20. Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.
    Hackl A, Ehren R, Kirschfink M, Zipfel PF, Beck BB, Weber LT, Habbig S.
    Pediatr Nephrol; 2017 Jun 10; 32(6):1081-1087. PubMed ID: 28220235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.